MedTrace Logo

Preventing Infections in Orthopaedic Patients

NCT02948387 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-10-28

No results posted yet for this study

Summary

Determine if antibiotic prophylaxis with intravenous cephalosporin and aminoglycoside in patients with Type II and II open fractures is safe and effective.

Conditions

  • Open Fracture

Sponsors & Collaborators

  • Forest Laboratories

    collaborator INDUSTRY

  • Olayemi Osiyemi MD

    lead OTHER

Principal Investigators

  • Olayemi Osiyemi, MD · Triple O Research Institute PA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-10-31
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948387 on ClinicalTrials.gov